FDA workshop to explore AI’s impact on imaging
AI’s impact on medical imaging continues to be one of the most significant trends of the last several years, and now the FDA has announced a public workshop focused on that very subject.
The two-day workshop, “Evolving Role of Artificial Intelligence in Radiological Imaging,” is scheduled for February 25-26, 2020, the National Institutes of Health main campus in Bethesda, Maryland. Information presented to attendees will include an overview of medical device regulations, recommended techniques for validating AI-powered solutions and more.
“Through this workshop, FDA is seeking to engage with stakeholders to explore benefits and risks of these evolving applications of AI in radiology,” according to a prepared statement from the FDA. “As the benefit-risk profile changes, it is critical to adapt the methods used to evaluate and characterize their performance. In this workshop, FDA is also seeking innovative and consistent ways to leverage existing methods and to develop new methods for validation of these AI-based algorithms and explore opportunities for stakeholder collaboration in these efforts.”
There is no fee for registering for the workshop, though tickets are available on a first-come, first-served basis. Sessions will also be filmed and shared with those who can not attend in person.
Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.